UK Markets closed

LENSAR, Inc. (LNSR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.15+0.13 (+2.16%)
As of 12:26PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close6.02
Open6.18
Bid6.15 x 3100
Ask6.44 x 1000
Day's range5.96 - 6.15
52-week range5.50 - 9.83
Volume519
Avg. volume10,012
Market cap67.385M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-2.45
Earnings date08 Mar 2022 - 14 Mar 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est17.50
  • Business Wire

    LENSAR to Present at the H.C. Wainwright Virtual BioConnect Conference

    ORLANDO, Fla., January 04, 2022--LENSAR, Inc. (NASDAQ: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced Nick Curtis, Chief Executive Officer, will present at the H.C. Wainwright Virtual BioConnect Conference.

  • Simply Wall St.

    Shareholders in LENSAR (NASDAQ:LNSR) are in the red if they invested a year ago

    Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that...

  • Business Wire

    LENSAR to Present at Two Upcoming Investor Conferences

    ORLANDO, Fla., November 16, 2021--LENSAR, Inc. (NASDAQ: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced Nick Curtis, Chief Executive Officer will present at two upcoming investor conferences: